Cypre's blog to discuss the latest movements in science.
Our collaborator at Charles River, Julia Schüler, PhD DVM wrote a blog post titled Finally, Reliable Drug Screening Platforms for Lung Cancer Biomarkers, discussing the impact of 3D Tumor Models in screening patient-derived NSCLC tumors.
Partner with Cypre to generate translational insights using our 3D tumor microenvironment organoid platform. From targeting the tumor or stroma, to modulating the immune system, we’re built for collaboration.
